Delinquency trend drugs and pharmaceutical industry India 2017-2020

Published by A. Minhas, Jul 12, 2023
From 2017 to 2020, share of non-performing assets (NPAs) in the drug and pharmaceuticals industry in India has seen a gradual decline every quarter. As of February 2020, the NPAs of the industry stood at 9.5 percent with a decline of over three percent within a year's span.

Delinquency trend drugs and pharmaceutical industry in India from March 2017 to February 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2020

Region

India

Survey time period

March 2017 to February 2020

Citation formats
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in India

Global overview

5

Market overview

5

Trade

5

Investment and deals

4

Key players

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu